Antimalarials: unapproved uses or indications
Identifieur interne : 002571 ( Main/Exploration ); précédent : 002570; suivant : 002572Antimalarials: unapproved uses or indications
Auteurs : Ronni Wolf [Israël] ; Danny Wolf [Israël] ; Vincenzo Ruocco [Italie]Source :
- Clinics in Dermatology [ 0738-081X ] ; 2000.
English descriptors
- Teeft :
- Acad, Acad dermatol, Acta, Acta derm venereol, Actinic, Actinic lichen planus, Actinic reticuloid, Agents actions, Annulare, Antimalarial, Antimalarial agent, Antimalarial compounds, Antimalarial drugs, Apoptosis, Arch dermatol, Arthritis, Arthritis rheum, Atabrine, Atopic dermatitis, Beneficial effects, Biochem, Biol, British tuberculosis association, Bullosa, Cell biol, Cell proliferation, Childhood dermatomyositis, Chloroquine, Chloroquine binding, Chloroquine phosphate, Chloroquine therapy, Chloroquine treatment, Chronic actinic dermatitis, Chronic erythema nodosum, Cinchona, Clin, Clinic, Corticosteroid, Cutanea, Cutaneous, Cutaneous lesions, Cutaneous sarcoidosis, Derm, Dermatitis, Dermatol, Dermatology, Dermatomyositis, Dos, Effective therapy, Epidermolysis, Epidermolysis bullosa, Epidermolysis bullosa hereditaria, Eruption, Erythema, Erythema nodosum, Erythematosus, Generalized granuloma annulare, Granuloma, Histamine, Histocompatibility, Hydroxychloroquine, Hydroxychloroquine treatment, Inhibitor, Lesion, Lichen, Lichen planus, Lichen planus actinicus, Lichen sclerosus, Lupus, Lupus erythematosus, Lysosomotropic amines, Macrophage, Mcchesney, Melanin, Muscle involvement, Muscle weakness, Nitric, Nitric oxide, Nodosum, Oral lichen planus, Oral pathol, Oral surg, Panniculitis, Pharmacol, Phospholipase, Planus, Polymorphous, Polymorphous light eruption, Porphyria, Porphyria cutanea tarda, Primary syndrome, Proc natl acad, Protective effect, Pseudopelade, Psoriasis, Psoriatic, Psoriatic arthritis, Pulmonary sarcoidosis, Quinacrine, Quinacrine hydrochloride, Quinine, Rash, Remission, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Sarcoidosis, Significant decrease, Skin lesions, Solar urticaria, Spectral shift, Steroid, Stockh, Stomatitis, Syndrome, Synthetic models, Systemic, Systemic corticosteroids, Systemic lupus erythematosus, Systemic steroids, Tarda, Therapy, Tissue distribution, Transglutaminase, Transglutaminase activity, Venereol, Vesicle.
Url:
DOI: 10.1016/S0738-081X(99)00092-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000021
- to stream Istex, to step Curation: 000021
- to stream Istex, to step Checkpoint: 001389
- to stream Main, to step Merge: 002599
- to stream Main, to step Curation: 002571
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antimalarials: unapproved uses or indications</title>
<author><name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</author>
<author><name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
</author>
<author><name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FC4F9EDF7F761B7D5166AD02E9022AF8A3618BD9</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0738-081X(99)00092-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-76P0K43Z-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000021</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000021</idno>
<idno type="wicri:Area/Istex/Curation">000021</idno>
<idno type="wicri:Area/Istex/Checkpoint">001389</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001389</idno>
<idno type="wicri:doubleKey">0738-081X:2000:Wolf R:antimalarials:unapproved:uses</idno>
<idno type="wicri:Area/Main/Merge">002599</idno>
<idno type="wicri:Area/Main/Curation">002571</idno>
<idno type="wicri:Area/Main/Exploration">002571</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Antimalarials: unapproved uses or indications</title>
<author><name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
<affiliation wicri:level="1"><country xml:lang="fr">Israël</country>
<wicri:regionArea>the Department of Dermatology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv</wicri:regionArea>
<wicri:noRegion>Tel-Aviv</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Israël</country>
<wicri:regionArea>Address correspondence to Ronni Wolf, MD, Dept. of Dermatology, Tel-Aviv Sourasky Medical Center, 6 Weizman St., Tel-Aviv 64239</wicri:regionArea>
<wicri:noRegion>Tel-Aviv 64239</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
<affiliation wicri:level="1"><country xml:lang="fr">Israël</country>
<wicri:regionArea>the Pediatric Outpatient Clinic, Hasharon Region, Kupat Holim</wicri:regionArea>
<wicri:noRegion>Kupat Holim</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>the Department of Dermatology, University of Naples II, School of Medicine and Surgery, Naples</wicri:regionArea>
<wicri:noRegion>Naples</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinics in Dermatology</title>
<title level="j" type="abbrev">CID</title>
<idno type="ISSN">0738-081X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">18</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="17">17</biblScope>
<biblScope unit="page" to="35">35</biblScope>
</imprint>
<idno type="ISSN">0738-081X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0738-081X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acad</term>
<term>Acad dermatol</term>
<term>Acta</term>
<term>Acta derm venereol</term>
<term>Actinic</term>
<term>Actinic lichen planus</term>
<term>Actinic reticuloid</term>
<term>Agents actions</term>
<term>Annulare</term>
<term>Antimalarial</term>
<term>Antimalarial agent</term>
<term>Antimalarial compounds</term>
<term>Antimalarial drugs</term>
<term>Apoptosis</term>
<term>Arch dermatol</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Atabrine</term>
<term>Atopic dermatitis</term>
<term>Beneficial effects</term>
<term>Biochem</term>
<term>Biol</term>
<term>British tuberculosis association</term>
<term>Bullosa</term>
<term>Cell biol</term>
<term>Cell proliferation</term>
<term>Childhood dermatomyositis</term>
<term>Chloroquine</term>
<term>Chloroquine binding</term>
<term>Chloroquine phosphate</term>
<term>Chloroquine therapy</term>
<term>Chloroquine treatment</term>
<term>Chronic actinic dermatitis</term>
<term>Chronic erythema nodosum</term>
<term>Cinchona</term>
<term>Clin</term>
<term>Clinic</term>
<term>Corticosteroid</term>
<term>Cutanea</term>
<term>Cutaneous</term>
<term>Cutaneous lesions</term>
<term>Cutaneous sarcoidosis</term>
<term>Derm</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatology</term>
<term>Dermatomyositis</term>
<term>Dos</term>
<term>Effective therapy</term>
<term>Epidermolysis</term>
<term>Epidermolysis bullosa</term>
<term>Epidermolysis bullosa hereditaria</term>
<term>Eruption</term>
<term>Erythema</term>
<term>Erythema nodosum</term>
<term>Erythematosus</term>
<term>Generalized granuloma annulare</term>
<term>Granuloma</term>
<term>Histamine</term>
<term>Histocompatibility</term>
<term>Hydroxychloroquine</term>
<term>Hydroxychloroquine treatment</term>
<term>Inhibitor</term>
<term>Lesion</term>
<term>Lichen</term>
<term>Lichen planus</term>
<term>Lichen planus actinicus</term>
<term>Lichen sclerosus</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Lysosomotropic amines</term>
<term>Macrophage</term>
<term>Mcchesney</term>
<term>Melanin</term>
<term>Muscle involvement</term>
<term>Muscle weakness</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Nodosum</term>
<term>Oral lichen planus</term>
<term>Oral pathol</term>
<term>Oral surg</term>
<term>Panniculitis</term>
<term>Pharmacol</term>
<term>Phospholipase</term>
<term>Planus</term>
<term>Polymorphous</term>
<term>Polymorphous light eruption</term>
<term>Porphyria</term>
<term>Porphyria cutanea tarda</term>
<term>Primary syndrome</term>
<term>Proc natl acad</term>
<term>Protective effect</term>
<term>Pseudopelade</term>
<term>Psoriasis</term>
<term>Psoriatic</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary sarcoidosis</term>
<term>Quinacrine</term>
<term>Quinacrine hydrochloride</term>
<term>Quinine</term>
<term>Rash</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Sarcoidosis</term>
<term>Significant decrease</term>
<term>Skin lesions</term>
<term>Solar urticaria</term>
<term>Spectral shift</term>
<term>Steroid</term>
<term>Stockh</term>
<term>Stomatitis</term>
<term>Syndrome</term>
<term>Synthetic models</term>
<term>Systemic</term>
<term>Systemic corticosteroids</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic steroids</term>
<term>Tarda</term>
<term>Therapy</term>
<term>Tissue distribution</term>
<term>Transglutaminase</term>
<term>Transglutaminase activity</term>
<term>Venereol</term>
<term>Vesicle</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Israël</li>
<li>Italie</li>
</country>
</list>
<tree><country name="Israël"><noRegion><name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</noRegion>
<name sortKey="Wolf, Danny" sort="Wolf, Danny" uniqKey="Wolf D" first="Danny" last="Wolf">Danny Wolf</name>
<name sortKey="Wolf, Ronni" sort="Wolf, Ronni" uniqKey="Wolf R" first="Ronni" last="Wolf">Ronni Wolf</name>
</country>
<country name="Italie"><noRegion><name sortKey="Ruocco, Vincenzo" sort="Ruocco, Vincenzo" uniqKey="Ruocco V" first="Vincenzo" last="Ruocco">Vincenzo Ruocco</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002571 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002571 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:FC4F9EDF7F761B7D5166AD02E9022AF8A3618BD9 |texte= Antimalarials: unapproved uses or indications }}
This area was generated with Dilib version V0.6.33. |